FDA approves second Alzheimer’s drug that can slow onset of disease
Federal health authorities on Tuesday gave approval to an experimental new drug that has shown to delay the onset of Alzheimer’s disease in trials.
Donanemab, manufactured by Eli Lilly, is the second medication that has won the blessing of the Food a... [3358 chars]
Source: The Guardian
